Previous 10 | Next 10 |
Full recruitment secures the target number of completer patients Multiple primary endpoints include reduction in agitation and aggression and overall disease improvement Topline efficacy data expected in Q1 2024 Recent predefined Interim Analysis qualified PORTICO as non...
2023-07-25 17:35:57 ET Orion Group ( NYSE: ORN ) is scheduled to announce Q2 earnings results on Wednesday, July 26th, after market close. The consensus EPS Estimate is -$0.14 (-40.0% Y/Y) and the consensus Revenue Estimate is $179.73M (-8.1% Y/Y). Over the last 2 year...
Positive aggregate safety data from vafidemstat's PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent with safety data from seven completed clinical trials, supporting the drug is safe and well-tolerated Continues to enroll patients in Phase IIb EVOLUTION trial wi...
HOUSTON, July 17, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the "Company"), a leading specialty construction company, today announced that it will issue its financial results for the second quarter ended June 30, 2023 on Wednesday, July 26, 2023, after the close of the stoc...
Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial based on positive safety data from the initial 167 randomized patients PORTICO plans to recruit 188 patients MADRID, Spain and BOSTON, July 05, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomic...
All resolutions were approved. 35% of the issued shares represented. MADRID, Spain and BOSTON, June 27, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases...
2023-06-26 13:39:09 ET Orion Group ( NYSE: ORN ) has undertaken two real estate sale-leaseback transactions for a total value of $20.3 million, the company said Monday. The company said it entered into a sale-leaseback agreement for its Baytown Pipe Yard property in Bayto...
HOUSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today announced two real estate sale-leaseback transactions for a total value of $20.3 million. The Company entered into a sale-leasebac...
Comprehensively reversed disease progression symptoms in a CMT mice model Selected for an oral presentation A highly selective and safe HDAC-6 inhibitor To start IND-enabling studies soon MADRID, Spain and BOSTON, June 21, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, ...
Selected for Oral Presentation Study done in the CMT1A mouse model Supported by the CMT Research Foundation MADRID, Spain and BOSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leverag...
News, Short Squeeze, Breakout and More Instantly...
Orion Group Holdings Inc. Common Company Name:
ORN Stock Symbol:
NYSE Market:
Orion Group Holdings Inc. Common Website:
MADRID and CAMBRIDGE, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that it has received “Deci...
HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (“Orion”, "Company"), a leading specialty construction company, today announced that it will issue its second quarter 2024 financial results after the close of the stock market on Wednesday, July 24, 2...
2024-07-06 15:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...